Takamichi Ito Selected Research

5-((glucopyranosyloxy)methyl)uracil

9/2022

Concordance in judgment of clinical borders of basal cell carcinomas in Japanese patients: A preliminary study of JCOG2005 (J-BASE-MARGIN).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takamichi Ito Research Topics

Disease

16	Neoplasms (Cancer) 01/2022 - 04/2013
13	Melanoma (Melanoma, Malignant) 08/2022 - 02/2012
5	Atopic Dermatitis (Atopic Eczema) 09/2020 - 01/2017
5	Inflammation (Inflammations) 03/2020 - 01/2018
5	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020 - 01/2018
4	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2013
4	Diabetic Nephropathies (Diabetic Nephropathy) 02/2007 - 01/2004
3	Hemangiosarcoma (Angiosarcoma) 01/2022 - 01/2016
2	Drug Eruptions (Drug Eruption) 07/2021 - 05/2014
2	Ischemia 05/2021 - 07/2017
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2021 - 01/2017
2	Extramammary Paget Disease (Paget Disease, Extramammary) 02/2021 - 01/2021
2	Pruritus (Itching) 09/2020 - 03/2020
2	Wounds and Injuries (Trauma) 12/2019 - 01/2004
2	Skin Ulcer 12/2019 - 04/2015
2	Psoriatic Arthritis 08/2019 - 11/2018
2	Carcinogenesis 01/2017 - 12/2013
2	Bowen's Disease (Disease, Bowen) 01/2017 - 11/2014
2	Nevus (Nevi) 12/2013 - 06/2013
2	Body Weight (Weight, Body) 02/2007 - 02/2006
1	Basal Cell Carcinoma (Rodent Ulcer) 09/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Margins of Excision 01/2022
1	Skin Neoplasms (Skin Cancer) 01/2022
1	Fever (Fevers) 02/2021
1	Lichen Planus (Lichen Ruber Planus) 02/2021
1	COVID-19 02/2021
1	Dermatitis 02/2019
1	Necrosis 01/2018
1	Ganglion Cysts (Ganglion) 07/2017
1	Fasciitis (Fascitis) 07/2017
1	Sunburn 01/2017

Drug/Important Bio-Agent (IBA)

5	NectinsIBA 01/2022 - 08/2020
5	Immune Checkpoint InhibitorsIBA 02/2021 - 01/2018
5	Biological ProductsIBA 11/2018 - 01/2015
5	Proteins (Proteins, Gene)FDA Link 06/2018 - 01/2004
4	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 01/2021
4	Cell Adhesion MoleculesIBA 01/2022 - 08/2020
4	Interleukin-17 (Interleukin 17)IBA 09/2020 - 01/2018
3	Blood Glucose (Blood Sugar)IBA 07/2009 - 02/2006
3	CreatinineIBA 02/2007 - 01/2004
2	sacituzumab govitecanIBA 01/2022 - 07/2021
2	Surface Antigens (Surface Antigen)IBA 01/2022 - 07/2021
2	enfortumab vedotinIBA 01/2022 - 08/2020
2	monomethyl auristatin EIBA 01/2022 - 01/2021
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 01/2021
2	Interleukin-13IBA 09/2020 - 12/2019
2	Filaggrin ProteinsIBA 06/2018 - 01/2017
2	Thiostrepton (Gargon)IBA 07/2016 - 01/2016
2	Small Interfering RNA (siRNA)IBA 07/2016 - 01/2016
2	Transcription Factors (Transcription Factor)IBA 07/2016 - 01/2016
2	Matrix Metalloproteinases (MMPs)IBA 12/2013 - 01/2004
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 12/2013 - 01/2004
2	Keratins (Keratin)IBA 06/2013 - 04/2013
2	Glucose (Dextrose)FDA LinkGeneric 07/2009 - 01/2004
2	PyridoxamineIBA 07/2009 - 02/2007
2	Advanced Glycation End ProductsIBA 02/2007 - 02/2006
2	AlbuminsIBA 02/2007 - 02/2006
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 02/2007 - 01/2004
1	5-((glucopyranosyloxy)methyl)uracilIBA 09/2022
1	AntibodiesIBA 08/2022
1	AntigensIBA 01/2022
1	src-Family KinasesIBA 01/2022
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 07/2021
1	Cyclin-Dependent Kinase 4IBA 07/2021
1	NivolumabIBA 05/2021
1	encorafenibIBA 03/2021
1	binimetinibIBA 03/2021
1	trametinibIBA 02/2021
1	dabrafenibIBA 02/2021
1	Pharmaceutical PreparationsIBA 08/2020
1	Interleukin-33IBA 03/2020
1	Interleukin-1 (Interleukin 1)IBA 03/2020
1	CytokinesIBA 03/2020
1	InterleukinsIBA 01/2020
1	ChemokinesIBA 01/2020
1	indirubinIBA 12/2019
1	Interleukin-4 (Interleukin 4)IBA 12/2019
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 12/2019
1	SmokeIBA 04/2019
1	Benzo(a)pyreneIBA 04/2019
1	Environmental Pollutants (Pollutants, Environmental)IBA 04/2019
1	Interleukin-6 (Interleukin 6)IBA 04/2019
1	6-formylindolo(3,2-b)carbazoleIBA 02/2019
1	PeriostinIBA 01/2019
1	Interleukin-23 (Interleukin 23)IBA 01/2018
1	Dacarbazine (DIC)FDA LinkGeneric 08/2017
1	Fluconazole (Zonal)FDA LinkGeneric 07/2017
1	pheomelaninIBA 01/2017
1	Imatinib Mesylate (Gleevec)FDA Link 01/2017
1	Melanocyte-Stimulating Hormones (MSH)IBA 01/2017
1	CateninsIBA 01/2017
1	Neutralizing AntibodiesIBA 01/2017
1	eumelaninIBA 01/2017
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2017

Therapy/Procedure

11	Therapeutics 08/2022 - 01/2019
2	Drug Therapy (Chemotherapy) 02/2021 - 08/2017
2	Molecular Targeted Therapy 01/2021 - 06/2016
1	Mohs Surgery (Mohs' Micrographic Surgery) 01/2022
1	Operative Surgical Procedures 02/2020